Research ArticleBasic Science Investigations
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura, Shozo Furumoto, Ryuichi Harada, Tetsuro Tago, Takeo Yoshikawa, Michelle Fodero-Tavoletti, Rachel S. Mulligan, Victor L. Villemagne, Hiroyasu Akatsu, Takayuki Yamamoto, Hiroyuki Arai, Ren Iwata, Kazuhiko Yanai and Yukitsuka Kudo
Journal of Nuclear Medicine August 2013, 54 (8) 1420-1427; DOI: https://doi.org/10.2967/jnumed.112.117341
Nobuyuki Okamura
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Shozo Furumoto
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
2Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Ryuichi Harada
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Tetsuro Tago
2Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Takeo Yoshikawa
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Michelle Fodero-Tavoletti
3Department of Pathology, University of Melbourne, Victoria, Australia
Rachel S. Mulligan
4Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Victoria, Australia
Victor L. Villemagne
4Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Victoria, Australia
Hiroyasu Akatsu
5Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
Takayuki Yamamoto
5Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan
Hiroyuki Arai
6Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; and
Ren Iwata
2Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Kazuhiko Yanai
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Yukitsuka Kudo
7Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura, Shozo Furumoto, Ryuichi Harada, Tetsuro Tago, Takeo Yoshikawa, Michelle Fodero-Tavoletti, Rachel S. Mulligan, Victor L. Villemagne, Hiroyasu Akatsu, Takayuki Yamamoto, Hiroyuki Arai, Ren Iwata, Kazuhiko Yanai, Yukitsuka Kudo
Journal of Nuclear Medicine Aug 2013, 54 (8) 1420-1427; DOI: 10.2967/jnumed.112.117341
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura, Shozo Furumoto, Ryuichi Harada, Tetsuro Tago, Takeo Yoshikawa, Michelle Fodero-Tavoletti, Rachel S. Mulligan, Victor L. Villemagne, Hiroyasu Akatsu, Takayuki Yamamoto, Hiroyuki Arai, Ren Iwata, Kazuhiko Yanai, Yukitsuka Kudo
Journal of Nuclear Medicine Aug 2013, 54 (8) 1420-1427; DOI: 10.2967/jnumed.112.117341
Jump to section
Related Articles
Cited By...
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- 18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
- Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
- Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
- Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET
- Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects
- Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules
- Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
- In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317
- Tau Positron Emission Tomography Imaging
- Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
- In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET
- Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
- Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models
- Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
- Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease
- New Targets for the Development of PET Tracers for Imaging Neurodegeneration in Alzheimer Disease
- Molecular Imaging of Alzheimer Disease Pathology
- Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers